Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (2)
  • Drug Metabolite
    (1)
  • IDO
    (1)
  • Indoleamine 2,3-Dioxygenase (IDO)
    (1)
  • NOD
    (1)
  • PROTACs
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

sin 10

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • PROTAC Products
    1
    TargetMol | PROTAC
Molsidomine
SIN-10, Morsydomine, Corvaton
T010925717-80-0
Molsidomine (Corvaton) is an orally active, long-acting vasodilating drug. It metabolizes in the liver to the active metabolite linsidomine, that releases nitric oxide (NO) upon decay as the actual vasodilating compound.
  • $30
In Stock
Size
QTY
Beta-defensin 103 isoform X1, pig
T76064
Beta-defensin 103 isoform X1, pig, is an antimicrobial peptide found in various organisms, essential for the initial defense mechanisms of the innate immune system against pathogens [1].
  • Inquiry Price
Inquiry
Size
QTY
Beta-defensin 103 isoform X1, pig TFA
T76064L
Beta-defensin 103 isoform X1, pig TFA, is an antimicrobial peptide found in various living organisms, crucial for the initial defense of the innate immune system against pathogens [1].
  • Inquiry Price
Inquiry
Size
QTY
PROTAC IDO1 Degrader-1
PROTAC IDO1 Degrader-1
T373292488851-89-2
PROTAC IDO1 Degrader-1, a pioneering compound, efficiently targets indoleamine 2,3-dioxygenase 1 (IDO1) for ubiquitination and degradation by recruiting IDO1 to the CRBN E3 ligase, thereby facilitating its entry into the ubiquitin-proteasome system (UPS) with a DC50 of 2.84 μM. This compound also moderately enhances the tumor-killing efficacy of HER2 CAR-T cells[1].
  • $697
Inquiry
Size
QTY
DW532
T710821267949-42-7
DW532 is one of simplified analogues of hematoxylin that has shown broad-spectrum inhibition on tyrosine kinases and in vitro anti-cancer activities. DW532 inhibited EGFR and VEGFR2 in vitro kinase activity (the IC50 values were 4.9 and 5.5 μmol/L, respectively), and suppressed their downstream signaling. DW532 dose-dependently inhibited tubulin polymerization via direct binding to tubulin, thus disrupting the mitotic spindle assembly and leading to abnormal cell division. In a panel of human cancer cells, DW532 (1 and 10 μmol/L) induced G2/M phase arrest and cell apoptosis, which subsequently resulted in cytotoxicity. Knockdown of BubR1 or Mps1, the two core proteins of the spindle assembly checkpoint dramatically decreased DW532-induced cell cycle arrest in MDA-MB-468 cells. Moreover, treatment with DW532 potently and dose-dependently suppressed angiogenesis in vitro and in vivo. ( Acta Pharmacol Sin. 2014 Jul;35(7):916-28.)
  • $1,520
6-8 weeks
Size
QTY